摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

3-methyl-1-phenyl-4-diphenylacetyl-pyrazol-5-one | 861102-35-4

中文名称
——
中文别名
——
英文名称
3-methyl-1-phenyl-4-diphenylacetyl-pyrazol-5-one
英文别名
4-diphenylacetyl-3-methyl-1-phenyl-pyrazol-5-one;HQCHPh2
3-methyl-1-phenyl-4-diphenylacetyl-pyrazol-5-one化学式
CAS
861102-35-4
化学式
C24H20N2O2
mdl
——
分子量
368.435
InChiKey
NZUOJNVTUMEHSM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    4.9
  • 重原子数:
    28.0
  • 可旋转键数:
    5.0
  • 环数:
    4.0
  • sp3杂化的碳原子比例:
    0.08
  • 拓扑面积:
    55.12
  • 氢给体数:
    1.0
  • 氢受体数:
    4.0

反应信息

  • 作为反应物:
    描述:
    3-methyl-1-phenyl-4-diphenylacetyl-pyrazol-5-one乙醇 为溶剂, 生成 [N,N'-propylenebis(3-methyl-1-phenyl-4-diphenylacetylimmine-pyrazol-5-one)]diaquozinc(II)
    参考文献:
    名称:
    Group 12 metal complexes of tetradentate N2O2–Schiff-base ligands incorporating pyrazole
    摘要:
    New [M(Q)(2)(X)] derivatives (where M=Zn, Cd or Hg; Q=1-phenyl-3-methyl-4-R(C=O)-pyrazolon-5-ato; in detail: Q(L), R=C6H5; Q(B), R=CH2C(CH3)(3); Q(S), R=CH(C6H5)(2); X=EtOH or H2O) have been synthesised and characterised. These compounds undergo a condensation reaction with the appropriate diamine in ethanol, affording novel Schiff-base metal derivatives [M(diaquo)bis(1-phenyl-3-methyl-4-R(C=N)-pyrazolone)(CH2)(n)diimmine] ((LH2)-H-n, R=C6H5, n=2, 3 or 4; (BH2)-H-n, R-CH2C(CH3)(3), n=2, 3 or 4; (SH2)-H-n, Cd-113 NMR study has R=CH(C6H5)(2), n=2 or 3; M=Zn, Cd or Hg). These compounds possess a six-coordinate metal environment. A been carried out on cadmium derivatives. The derivative [Zn(L-2)(H2O)(2)] reacted with CuCl2 and with Cu(CIO4)(2) affording [Cu(Q(L))(2)] and [Cu(en)(2)](ClO4)(2) (en=ethylendiamine), respectively, upon breaking of the C=N bond in the Schiff-base donor. In addition [Zn(L-2)(H2O)(2)] reacted with 1,10-phenanthroline (phen), yielding the derivative [Zn(Q(L))(2)(phen)]. Whereas when [Zn(L-2)(H2O)(2)] reacted with CdCl2, formation of [Cd(L-2)(H2O)(2)] due to exchange of the metal centre was observed. Finally the derivative [Zn(L-2)(Hmimt)], likely containing a five-coordinate ZnN2O2S central core, has been obtained from the exchange reaction between [Zn(L-2)(H2O)(2)] and 1-methylimidazolin-2-thione (Hmimt). (C) 1999 Elsevier Science Ltd. All rights reserved.
    DOI:
    10.1016/s0277-5387(99)00230-2
点击查看最新优质反应信息

文献信息

  • Novel bis(β-diketonato)diorganotin(IV) derivatives containing bulky 4-acyl-5-pyrazolonato ligands: Influence of the steric hindrance of the acyl moiety on the solid state structures of tin complexes and their behaviour in solution
    作者:Francesco Caruso、Corrado Di Nicola、John V. Hanna、Fabio Marchetti、Claudio Pettinari、Riccardo Pettinari、Miriam Rossi、Gregory J. Rees、Brian W. Skelton、Allan H. White
    DOI:10.1016/j.ica.2010.12.008
    日期:2011.2
    = CH3, C2H5, C6H11, n- and t-C4H9, C6H5,) have been synthesised and characterised by analytical and spectral techniques. Variable temperature NMR studies of (QCHPh2)2SnR2 derivatives (R = CH3 and C2H5) in chlorohydrocarbon solvents indicate a fluxional behaviour, with rapid interconversion between six- and five-coordinate species, the latter containing a bidentate acylpyrazolonate and a monodentate
    新的(Q)2SnR2衍生物(一般为总部;详细信息:HQCHPh2 = 4-二苯基乙酰基-3-甲基-1-苯基-5-吡唑酮; HQBn = 3-甲基-1-苯基-4-苯基乙酰基-5-吡唑啉酮;已合成HQnaph = 3-甲基-4-甲酰基-1-苯基-5-吡唑啉酮; R = CH3C2H5C6H11,n-和t-C4H9C6H5),并通过分析和光谱技术进行了表征。(QCHPh2)2SnR2衍生物(R = 和 )在代烃溶剂中的可变NMR研究表明,通量的行为具有六和五配位物质之间的快速相互转化,后者包含双齿酰基吡唑啉酸酯和单齿酰基。二有机锡(IV)衍生物(QCHPh2)2SnMe2,(QCHPh2)2SnEt2,(QBn)2SnMe2和(包括每个Qx家族的代表)的X射线晶体结构显示出偏心的反八面体构型的属中心。β-二酮酸酯供体的4-酰基部分具有立体效应,该立体效应与固态和溶液态的结构行为有关。(QBn)2SnR2(R
  • Influence of sterically demanding groups on the structure and stability in the solid and solution state of (acylpyrazolonate)bis(phosphine)copper(I) derivatives
    作者:Fabio Marchetti*、Claudio Pettinari、Riccardo Pettinari、Augusto Cingolani、Mercedes Camalli、Riccardo Spagna*
    DOI:10.1016/s0020-1693(99)00463-6
    日期:2000.2
    neutral derivatives [Cu(L)(PR 3 ) 2 ] (LH=1-phenyl-3-methyl-4-R 1 (CO)-pyrazol-5-one, in detail L 1 H, R 1 =C 6 H 5 ; L 2 H, R 1 =CH 3 ; L 3 H, R 1 =CF 3 ; L 4 H, R 1 =C 6 H 11 ; L 5 H, R 1 =C 6 H 5 CH 2 ; L 6 H, R 1 =(C 6 H 5 ) 2 CH; R=C 6 H 5 , p -CH 3 C 6 H 4 , C 6 H 5 CH 2 or C 6 H 11 ) and [Cu(L) 2 ] (L=L 4 , L 5 and L 6 ) have been synthesised and characterised by analytical and spectroscopic techniques
    摘要新的中性衍生物[Cu(L)(PR 3)2](LH = 1-苯基-3-甲基-4-R 1(CO)-吡唑-5-酮,更详细地为L 1 H,R 1 = C 6 H 5; L 2 H,R 1 = CH 3; L 3 H,R 1 = CF 3; L 4 H,R 1 = C 6 H 11; L 5 H,R 1 = C 6 H 5 CH 2; L 6 H,R 1 =(C 6 H 5)2 CH; R = C 6 H 5,对-CH 3 C 6 H 4,C 6 H 5 CH 2或C 6 H 11)和[Cu( L)2](L = L 4,L 5和L 6)已经合成并且通过分析和光谱技术表征。解析了[Cu(L 1)(PCy 3)2],[Cu(L 5)(PPh 3)2]和[Cu(L 6)(PPh 3)2]的X射线晶体和分子结构。 ,其中原子存在于严重扭曲的四面体CuO 2 P 2环境中。键合角度PCuP,PCuO和OCuO受PR
  • Tin( <scp>II</scp> ) and Lead( <scp>II</scp> ) 4‐Acyl‐5‐pyrazolonates: Synthesis, Spectroscopic and X‐ray Structural Characterization
    作者:Claudio Pettinari、Fabio Marchetti、Riccardo Pettinari、Augusto Cingolani、Eleonora Rivarola、Christine Phillips、Joseph Tanski、Miriam Rossi、Francesco Caruso
    DOI:10.1002/ejic.200400225
    日期:2004.9
    β-diketonate Sn(Q)2 complexes [HQ = 1-R1-3-R3-4-R4(C=O)-pyrazol-5-one; HQC: R1 = Ph, R3 = Me, R4 = Cy; HQS: R1 = Ph, R3 = Me, R4 = CHPh2; HQL: R1 = Ph, R3 = Me, R4 = CH2Ph; HQT: R1 = Ph, R3 = Me, R4 = CH2tBu; HQE: R1 = Ph, R3 = Me, R4 = Et; HQB: R1 = Ph, R3 = Me, R4 = tBu; HQW: R1 = Ph, R3 = Me, R4 = p-(tBu)Ph; HQR: R1 = Ph, R3 = Me, R4 = p-[(CH2)5CH3]Ph; HQN: R1 = p-NO2Ph, R3 = Me, R4 = Ph; HQM: R1 =
    新型 (II) β-二酮 Sn(Q)2 配合物 [HQ = 1-R1-3-R3-4-R4(C=O)-pyrazol-5-one; HQC:R1 = Ph,R3 = Me,R4 = Cy;HQS:R1 = Ph,R3 = Me,R4 = CHPh2;HQL:R1 = Ph,R3 = Me,R4 = Ph;HQT:R1 = Ph,R3 = Me,R4 = tBu;HQE:R1 = Ph,R3 = Me,R4 = Et;HQB:R1 = Ph,R3 = Me,R4 = tBu;HQW:R1 = Ph,R3 = Me,R4 = p-(tBu)Ph;HQR:R1 = Ph,R3 = Me,R4 = p-[(CH2)5CH3]Ph;HQN:R1 = p-NO2Ph,R3 = Me,R4 = Ph;HQM:R1 = Me,R3 = Me,R4 = Ph;总部:R1 = 我,R3 = 我,R4
  • Synthesis and characterization of silver(I) derivatives containing acylpyrazolonate and phosphino ligands: X-ray crystal structures of monomeric [Ag(QnPe)(PPh3)2] and of dimeric [{Ag(QnPe)(PiBu3)}2] (QnPe=1-phenyl-3-methyl-4-tert-butylacetylpyrazolon-5-ato)
    作者:Adriana Lorenzotti、Fabio Marchetti、Claudio Pettinari、Riccardo Pettinari、Brian W. Skelton、Allan H. White
    DOI:10.1016/j.ica.2005.04.017
    日期:2005.7
    C 6 H 5 , R 2 = CF 2 CF 3 ; R = Ph or iBu) have been synthesized and characterized in the solid state and solution. The crystal structure of 1-(4-trifluoromethylphenyl)-3-methyl-5-pyrazolone, the precursor of proligand HQ f M e and of derivatives [Ag(Q n P e )(PPh 3 ) 2 ] and [Ag(Q n P e )(PiBu 3 )] 2 have been investigated. [Ag(Q n P e )(PPh 3 ) 2 ] is a mononuclear compound with a silver atom in
    新的酰基吡唑甲酸(I)衍生物[Ag(Q)],[Ag(Q)(PR 3)] 2和[Ag(Q)(PR 3)2](HQ = 1-R 1 -3-methyl-4 -R 2(C = O)吡唑-5-酮,HQ B n = R 1 = C 6 H 5,R 2 = CH 2 C 6 H 5; HQ CHP h 2 = R1 = C 6 H 5,R 2 = CH(C 6 H 5)2; HQ n P e = R 1 = C 6 H 5,R 2 = CH 2 C(CH 3)3; HQ t B u = R 1 = C 6 H 5,R 2 = C(CH 3)3; HQ f M e = R 1 = C 6 H 4 -p-CF 3,R 2 = CF 3; HQ f E t = R 1 = C 6 H 5,R 2 = CF 2。 CF 3; R = Ph或iBu)已合成并在固态和溶液中进行了表征。1-(4-三甲基苯基)-3-甲基-5-吡唑酮配体HQ
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S,S)-邻甲苯基-DIPAMP (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(-)-4,12-双(二苯基膦基)[2.2]对环芳烷(1,5环辛二烯)铑(I)四氟硼酸盐 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(4-叔丁基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[(3-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-(+)-4,7-双(3,5-二-叔丁基苯基)膦基-7“-[(吡啶-2-基甲基)氨基]-2,2”,3,3'-四氢1,1'-螺二茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (R)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4S,4''S)-2,2''-亚环戊基双[4,5-二氢-4-(苯甲基)恶唑] (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (3aR,6aS)-5-氧代六氢环戊基[c]吡咯-2(1H)-羧酸酯 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[((1S,2S)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1S,2S,3R,5R)-2-(苄氧基)甲基-6-氧杂双环[3.1.0]己-3-醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (1-(2,6-二氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙蒿油 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫-d6 龙胆紫